Kite Earns Patent for Method to Increase Efficacy of CAR-T
Company Snags Rights for Use of Optimal Preconditioning Regimen
Seeking New Users for iSeq
The Changing Sequencing Landscape
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Cell Therapy Manufacturing: All Signs Point to Commercialization
As Milestones Are Reached, Best Practices Will Become Less Hazy
For full access to this article login to GEN Select now.
Managing PTMs in Protein Therapeutics
Ultimate Success of Biosimilars Linked to Adroit Handling of Post-Translational Modifications
- As more and more biopharmaceuticals move along the torturous process of development, clinical evaluation, and approval, dealing with changes to these complex protein molecules becomes increasingly paramount. A number of meetings and symposia have examined this question lately, and it’s clear that the technology is ramping up to successfully ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.